Johnson & Johnson Hit With $147M Verdict Over Medical Device Monopoly Tactics

Statement On $147M Verdict for AMDR Member Innovative Health Against Johnson & Johnson's Biosense Webster Medical Technology Unit - Finnoexpert

Statement On $147M Verdict for AMDR Member Innovative Health Against Johnson & Johnson's Biosense Webster Medical Technology Unit Source link

Statement On $147M Verdict for AMDR Member Innovative Health Against Johnson & Johnson’s Biosense Webster Medical Technology Unit

WASHINGTON & BERLIN–(BUSINESS WIRE)–Association of Medical Device Reprocessors issued the following statement: Friday’s unanimous verdict by a federal jury in Santa Ana, California for Innovative Health against Johnson & Johnson (NYSE: JNJ) is a victory for America’s hospitals, providers, patients, and the environment. The jury found that Biosense Webster violated federal and state antitrust laws by withholding clinical support to hospitals usin…

Johnson & Johnson Hit With $147M Verdict Over Medical Device Monopoly Tactics

Major antitrust ruling impacts hospital device costs and medical reprocessing competition. Court finds J&J unit blocked lower-cost alternatives. See full implications.